Sorensen Mel — SEC Form 4 filings

SEC reporting owner CIK 1444783. 4 Form 4 filings on record with FilingPulse; latest filed 2026-08-05.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-08-20 to 2026-08-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Galera Therapeutics, Inc. (GRTX)President and CEO, Director42 legs · 137,015 sh · $6,2323

Form 4 filings — Sorensen Mel

FiledFormIssuerReported transactionsSource
2026-08-054Galera Therapeutics, Inc. (GRTX)Disposition to issuer (D): 975 · Disposition to issuer (D): 30,000 (derivative)EDGAR
2025-11-244Galera Therapeutics, Inc. (GRTX)Sale (S): 70,000 @ $0.02EDGAR
2025-05-054Galera Therapeutics, Inc. (GRTX)Grant/award (A): 6,000,000 (derivative) @ $0EDGAR
2024-08-204Galera Therapeutics, Inc. (GRTX)Sale (S): 67,015 @ $0.07EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1444783 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →